BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 17235586)

  • 1. Systemic immune dysfunction in pancreatic cancer patients.
    Poch B; Lotspeich E; Ramadani M; Gansauge S; Beger HG; Gansauge F
    Langenbecks Arch Surg; 2007 May; 392(3):353-8. PubMed ID: 17235586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of pre-treatment immunological parameters in colorectal cancer patients with unresectable metastases to the liver.
    Zaloudik J; Lauerova L; Janakova L; Talac R; Simickova M; Nekulova M; Mikulikova I; Kovarik J; Sheard M
    Hepatogastroenterology; 1999; 46(25):220-7. PubMed ID: 10228796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic analysis of human peripheral blood lymphocytes by automatic sampling flow cytometry after stimulation with mitogens or allogeneic cells.
    Azzolina LS; Stevanoni G; Tommasi M; Tridente G
    Ric Clin Lab; 1990; 20(3):209-16. PubMed ID: 2237164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral blood lymphocytes of nonleukemic lymphoma patients exhibit aberrant expression of T-cell activation markers after polyclonal stimulation in vitro.
    Mangge H; Beaufort F; Neubauer M; Samitz M; Schauenstein K
    Cancer; 1990 Aug; 66(4):677-83. PubMed ID: 2386899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and local immunosuppression in pancreatic cancer patients.
    von Bernstorff W; Voss M; Freichel S; Schmid A; Vogel I; Jöhnk C; Henne-Bruns D; Kremer B; Kalthoff H
    Clin Cancer Res; 2001 Mar; 7(3 Suppl):925s-932s. PubMed ID: 11300493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-induced immunodeficiency. Relatively preserved phytohemagglutinin as opposed to decreased pokeweed mitogen responses may be due to possibly preserved responses via CD2/phytohemagglutinin pathway.
    Hofmann B; Jakobsen KD; Odum N; Dickmeiss E; Platz P; Ryder LP; Pedersen C; Mathiesen L; Bygbjerg IB; Faber V
    J Immunol; 1989 Mar; 142(6):1874-80. PubMed ID: 2564029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the induction of induced human CD4(+) CD25(+) FoxP3(+) T-regulatory cells and CD3(+) CD8(+) CD28(-) T-suppressor cells subset phenotypes in vitro: comparison of phorbol 12-myristate 13-acetate/ionomycin and phytohemagglutinin stimulation.
    Wang H; Daniel V; Sadeghi M; Opelz G
    Transplant Proc; 2013 Jun; 45(5):1822-31. PubMed ID: 23769052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High serum levels of soluble IL-2 receptor, cytokines, and C reactive protein correlate with impairment of T cell response in patients with advanced epithelial ovarian cancer.
    Macciò A; Lai P; Santona MC; Pagliara L; Melis GB; Mantovani G
    Gynecol Oncol; 1998 Jun; 69(3):248-52. PubMed ID: 9648596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome.
    Cetiner S; Demirhan O; Inal TC; Tastemir D; Sertdemir Y
    Int J Immunogenet; 2010 Aug; 37(4):233-7. PubMed ID: 20477881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal cell carcinoma-associated immune impairment that may interfere with the response to cytokine therapy.
    Lauerová L; Dusek L; Simícková M; Rovný F; Spurný V; Rovný A; Slampa P; Zaloudík J; Rejthar A; Wotke J; Kovarík J
    Neoplasma; 1999; 46(3):141-9. PubMed ID: 10613588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and release of IL-2 receptor and production of IL-2 by activated T lymphocyte subsets.
    Shahabuddin S
    J Clin Lab Immunol; 1991 Sep; 36(1):27-32. PubMed ID: 1668858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women.
    Khorram O; Yeung M; Vu L; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3590-6. PubMed ID: 9360512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
    Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
    In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response and cytokine profile among hepatitis C positive living donor renal transplant recipients.
    Justa S; Minz RW; Minz M; Sharma A; Pasricha N; Anand S; Chawla YK; Sakhuja VK
    Transplantation; 2010 Sep; 90(6):654-60. PubMed ID: 20622752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cytokines in children with immunodeficiencies].
    Kowalczyk D
    Folia Med Cracov; 1999; 40(1-2):5-97. PubMed ID: 10909468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foxp3(high) and Foxp3(low) Treg cells differentially correlate with T helper 1 and natural killer cells in peripheral blood.
    Lee SK; Kim JY; Jang BW; Hur SE; Na BJ; Lee M; Fukui A; Gilman-Sachs A; Kwak-Kim J
    Hum Immunol; 2011 Aug; 72(8):621-6. PubMed ID: 21600259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Th17 cytokines in leprosy: correlation with circulating CD4(+) CD25 (high)FoxP3 (+) T-regs cells, as well as down regulatory cytokines.
    Attia EA; Abdallah M; El-Khateeb E; Saad AA; Lotfi RA; Abdallah M; El-Shennawy D
    Arch Dermatol Res; 2014 Nov; 306(9):793-801. PubMed ID: 25018055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.